HomeAI · summaries
Storia in 4 fonti
Boulevard starts up with $65M to pursue targeted autoimmune drugs
Co-founded by pioneering researcher Georg Schett and ex-Sanofi CSO Frank Nestle, the startup is advancing a trio of multifaceted antibodies with the potential to treat several immune diseases.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
Boulevard starts up with $65M to pursue targeted autoimmune drugs
Co-founded by pioneering researcher Georg Schett and ex-Sanofi CSO Frank Nestle, the startup is advancing a trio of multifaceted antibodies with the potential to treat several…
- ·
statnews.com
Biotech company co-founded by top autoimmune researcher lays out plans with antibody therapies
German researcher Georg Schett has made a name for himself as a pioneer in autoimmune disease treatment. Now he's co-founding his own company.
